AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $665,496 | +79.4% | 23,700 | +109.7% | 0.01% | +100.0% |
| Q4 2021 | $371,000 | -69.4% | 11,300 | -48.7% | 0.00% | -76.9% |
| Q2 2021 | $1,214,000 | -15.2% | 22,035 | -20.6% | 0.01% | -23.5% |
| Q1 2021 | $1,432,000 | +82.4% | 27,736 | +23.7% | 0.02% | +13.3% |
| Q3 2020 | $785,000 | +15.8% | 22,428 | +77.0% | 0.02% | +66.7% |
| Q2 2020 | $678,000 | +196.1% | 12,668 | +95.9% | 0.01% | -35.7% |
| Q1 2020 | $229,000 | -60.6% | 6,468 | -41.2% | 0.01% | -85.9% |
| Q3 2016 | $581,000 | +82.7% | 11,000 | +40.3% | 0.10% | -23.8% |
| Q1 2016 | $318,000 | – | 7,841 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |